[Synacthen therapy and prostatic carcinoma?].
D000324:Adrenocorticotropic Hormone / Q000031:analogs & derivatives* / Q000627:therapeutic use; D003366:Cosyntropin / Q000009:adverse effects; D006801:Humans; D008297:Male; D008875:Middle Aged; D011471:Prostatic Neoplasms / Q000139:chemically induced*
D003366:Cosyntropin; D000324:Adrenocorticotropic Hormone
Synacthentherapie und Prostatakarzinom?